首页 正文

Review Biochimie. 2005 Jan;87(1):93-8. doi: 10.1016/j.biochi.2004.11.018 Q33.02025

Potential regulatory role of the farnesoid X receptor in the metabolic syndrome

法尼醇X受体在代谢综合征中可能的调节作用 翻译改进

Daniel Duran-Sandoval  1, Bertrand Cariou, Jean-Charles Fruchart, Bart Staels

作者单位 +展开

作者单位

  • 1 U.R.545 Inserm, Département d'Atherosclerosis, Institut Pasteur de Lille et Faculté de Pharmacie, Université de Lille 2, 1, rue du Professeur-Calmette, BP245, 59019 Lille, France.
  • DOI: 10.1016/j.biochi.2004.11.018 PMID: 15733743

    摘要 Ai翻译

    Dyslipidemia and gallbladder diseases are two current anomalies observed in patients suffering from the metabolic syndrome and type 2 diabetes. The bile acid-activated nuclear receptor farnesoid X receptor (FXR) controls bile acid as well as lipid metabolism. Recent observations indicate a role for FXR also in carbohydrate metabolism. Hepatic FXR expression is altered in diabetic animal models in vivo and regulated by hormones and nutrients in vitro. At the molecular level, FXR activation modifies the transcriptional activity of different transcription factors controlling gluconeogenesis and lipogenesis, thus affecting in concert bile acid, lipid and carbohydrate metabolism. The present review focuses on recent advances in our understanding of the modulation of carbohydrate metabolism by FXR. These observations raise the intriguing possibility for a modulatory role of this receptor also in the metabolic syndrome.

    Keywords:farnesoid x receptor; metabolic syndrome

    Copyright © Biochimie. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Biochimie

    缩写:BIOCHIMIE

    ISSN:0300-9084

    e-ISSN:1638-6183

    IF/分区:3.0/Q3

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Potential regulatory role of the farnesoid X receptor in the metabolic syndrome